/ Researchers / investigators / nagy-andras

  

Dr. Andras Nagy

Lunenfeld-Tanenbaum
Research Institute
Mount Sinai Hospital
Joseph & Wolf Lebovic Health Complex
6-1004 - 25 Orde St.
Toronto Ontario
M5T 3H7

Tel.: 416-586-4800 ext.3246

► Send Email

► Lab Website

► Web of Science Researcher ID
G-6465-2013

► Publons ID
2633560

► Publications

  

Dr. Andras Nagy

SENIOR INVESTIGATOR

In 2005, Dr. Andras Nagy established the Canada's first, and to date only, human embryonic stem cell lines. In 2009, Dr. Nagy reported the discovery of a new non-viral method of creating stem cells from other cells of the body that could lead to possible cures for devastating diseases including spinal cord injury, macular degeneration, diabetes and Parkinson's disease. In 2014, he led Project Grandiose, an international effort to map the genomic and proteomic pathways during de-differentiation of induced pluripotential stems cells. 

Previous approaches to establish stem cells from adult cells required the use of viruses to deliver the required genes, a method that carries the risk of damaging the DNA. Dr. Nagy's method not only does not require viruses but the stem cell transgenes necessary for the process of reprogramming can be seamlessly removed after they created stem cells. Therefore this method overcomes a major hurdle for the future of safe, personalized stem cell therapies in humans. Dr. Nagy's new method of generating stem cells does not require embryos as starting points and could be used to generate cells from many adult tissues such as a patient's own skin cells.

Dr. Nagy's research is a huge step forward on the path to new stem cell-based therapies and indicates that researchers at the Lunenfeld are at the leading edge of regenerative medicine. Regenerative medicine enables the human body to repair, replace, restore and regenerate its own damaged or diseased cells, tissues and organs.

Joining Mount Sinai Hospital in 1988, Dr. Nagy has been involved in mouse embryonic stem cell research since its early days. His research resulted in an important development in cancer research in 1996 that provided a new tool for researchers and pharmaceutical companies to test new and existing treatments for cancer.

Dr. Nagy has developed a broad spectrum of genomic technologies now used around the world. These technologies assist the study of gene function in development and disease, and are important tools in the development of stem cell based therapies. By using technologies to direct gene expression, scientists will gain control of stem cell behaviour, propagation and differentiation, which will be essential if stem cells are to be used to treat human disease.

With respect to future clinical use of these stem cells, the existence of mutant cells still introduces a significant risk of unexpected behaviour after cell transplantation, including the possibility of cancer formation. Recently, Dr. Nagy and his team found that  the early phase of the reprogramming process for induced Pluripotent Stem (iPS) cells is the root cause of acquired mutations.  Dr. Nagy and his lab are currently trying to protect the integrity of the genomic DNA of iPS cells during the reprogramming process by ensuring the safety of stem-cell-based therapies before they can be brought to clinical therapies and treatments.

At a Glance

Dr. Andras Nagy researches stem cells, tissue engineering and regenerative medicine

Discovered a new method to create pluripotent stem cells (cells that can develop into most other cell types) without risk of disrupting healthy genes

Established Canada's first human embryonic stem cell lines

He has also developed a broad spectrum of genomic technologies now used around the world

Dr. Nagy is the Canada Research Chair in Stem Cells and Regeneration

He was the only Canadian selected for the first annual Scientific American Top 10 Honour Roll in 2009

Major Research Activities

The Nagy laboratory is interested in using mouse genetics to study mammalian development and to apply this knowledge to human disease. Dr. Nagy is also developing new, powerful tools for genetic approaches and phenotype analysis for these ongoing studies. More recently he became interested in the biology of human pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells.

 

 

 

          
 LTRI
  About Us
   Senior Administration
   Research Committee
   Canada Research Continuity Emergency Fund
   Canada Research Chairs
   Technology Transfer
   Career Opportunities
  Researchers
   Investigators
    Dr. Irene L. Andrulis
    Dr. Rod Bremner
    Dr. Laurent Briollais
    Dr. Theodore J. Brown
    Dr. Shelley B. Bull
    Dr. Kieran Campbell
    Dr. Isabella Caniggia
    Dr. Robert F. Casper
    Dr. Graham L. Collingridge
    Dr. Sabine P. Cordes
    Dr. Joseph Culotti
    Dr. James Dennis
    Dr. Daniel J. Drucker
    Dr. Daniel Durocher
    Dr. Steven Gallinger
    Dr. Anne-Claude Gingras
    Dr. Pamela Goodwin
    Dr. Marc D. Grynpas
    Dr. Rayjean J. Hung
    Dr. Hartland W. Jackson
    Dr. Andrea Jurisicova
    Dr. Julia A. Knight
    Dr. Alexander G. Logan
    Dr. Stephen J. Lye
    Dr. Andras Nagy
    Dr. Michelle Nelson
    Dr. Kenichi Okamoto
    Dr. Laurence Pelletier
    Dr. Miguel Ramalho-Santos
    Dr. Frederick P. Roth
    Dr. Daniel Schramek
    Dr. Frank Sicheri
    Dr. Mark S. Silverberg
    Dr. Katherine Siminovitch
    Dr. Carolyn Steele Gray
    Dr. Ross Upshur
    Dr. Jim R. Woodgett
    Dr. Jeffrey Wrana
    Dr. Mei Zhen
    Dr. Bernard Zinman
   Clinician Scientists
    Dr. May Alarab
    Dr. Dominic Amato
    Dr. Amir Azarpazhooh
    Dr. Mrinalini Balki
    Dr. Chaim Bell
    Dr. Christine Brezden-Masley
    Dr. June C. Carroll
    Dr. Crystal Chan
    Dr. Martin C. Chang
    Dr. Kenneth Croitoru
    Dr. Ariel Dalfen
    Dr. Allan Detsky
    Dr. Brendan C. Dickson
    Dr. Rohan D. D’Souza
    Dr. Denice S. Feig
    Dr. Emer Finan
    Dr. John S. Floras
    Dr. Michael Fralick
    Dr. Shiphra R. Ginsburg
    Dr. Rebecca A. Gladdy
    Dr. Michael Goldberg
    Dr. Ellen Greenblatt
    Dr. Masoom A. Haider
    Dr. Jonathan J. Hunter
    Dr. Amna F. Husain
    Dr. Amish Jain
    Dr. Keith A. Jarvi
    Dr. Lianne P. Jeffs
    Dr. Jennie Johnstone
    Dr. Rita Kandel
    Dr. Edmond Kelly
    Dr. Erin D. Kennedy
    Dr. Edward C. Keystone
    Dr. James Khan
    Dr. John Kingdom
    Dr. Richard Kirsch
    Dr. Elena Kolomietz
    Dr. Caroline K. Kramer
    Dr. Stephen Lapinsky
    Dr. Shoo K. Lee
    Dr. Molyn Leszcz
    Dr. Susanna Mak
    Dr. Ann K. Malinowski
    Dr. Robert G. Maunder
    Dr. Taymaa May
    Dr. Allison McGeer
    Dr. Warren McIsaac
    Dr. Sangeeta Mehta
    Dr. Shikha Mittoo
    Dr. Ally Murji
    Dr. Kellie E. Murphy
    Dr. Geoffrey C. Nguyen
    Dr. Karel O'Brien
    Dr. Christian Pagnoux
    Dr. Claire Pain
    Dr. John Parker
    Dr. Bruce A. Perkins
    Dr. Allan Peterkin
    Dr. Aaron F. Pollett
    Dr. Paula Ravitz
    Dr. Albiruni A. Razak
    Dr. Ravi Retnakaran
    Dr. Robert H. Riddell
    Dr. Greg Ryan
    Dr. Joel Sadavoy
    Dr. Francisco J. Sanchez-Guerrero
    Dr. Amanda Selk
    Dr. Prakeshkumar Shah
    Dr. Vibhuti Shah
    Dr. Naveed Tahir Siddiqui
    Dr. Candice K. Silversides
    Dr. Daisy R. Singla
    Dr. Kim Tsoi
    Dr. Hillary A. Steinhart
    Dr. Carol Swallow
    Dr. Howard C. Tenenbaum
    Dr. Sharon L. Unger
    Dr. Chen Wang
    Dr. Alanna Weisman
    Dr. Virginia A. Wesson
    Dr. Lesley Wiesenfeld
    Dr. Rory Windrim
    Dr. Jay Wunder
    Dr. Alexandre Zlotta
   Staff Scientists
    Dr. Karen Colwill
    Dr. John Georgiou
    Dr. Gerald D. Gish
    Dr. Farzad Khalvati
    Dr. Colin Mckerlie
    Dr. Jinyi Zhang
   Associate Members / Scientists
    Dr. Gary D. Bader
    Dr. Bharati Bapat
    Dr. Marcus Bernardini
    Dr. Lisa D. Burry
    Dr. George S. Charames
    Dr. Mary Chiu
    Dr. Eleftherios P. Diamandis
    Dr. Sarah Ferguson
    Dr. Michael Glogauer
    Dr. Jack M. Goodman
    Dr. Tae Hart
    Dr. Johannes Keunen
    Dr. Sarina Isenberg
    Dr. Jordan Lerner-Ellis
    Dr. Zhong-Cheng Luo
    Dr. Stephen G. Matthews
    Dr. John R. McLaughlin
    Dr. Helen McNeill
    Dr. Massieh Moayedi
    Dr. Abdul Noor
    Dr. Ian M. Rogers
    Dr. Mike Tyers
    Dr. Pete Wegier
   Physician Directory
  Research Resources
   Our Research
   Expertise
  Training Centre
  News
   Spotlight
    Innovations in prostate cancer research during moustache season and beyond
    New genetic discoveries offer hope to IBD patients
    Diabetes: disease of the 21st century will affect approximately 500 million by 2030
    What does a worm’s nervous system tell us about disorders like Huntington’s Disease?
    The Year in Review: 2012 Highlights from the Samuel Lunenfeld Research Institute
    Millennials Help Scientists Transform Breast Cancer Research
    How Research Impacts Your Health
    2013 International Symposium: Frontiers in Diabetes Research
    $35 Million Gift from Larry and Judy Tanenbaum Launches Fundraising Drive for Endowment to Support Medical Research
    Director warns why we shouldn't neglect basic science in favour of applied science
    The anatomy of a major discovery
    Unravelling the mysteries of complex brain disorders
    LTRI Q&A: How do we predict breast cancer risk more effectively?
    Michal Zimmermann and his efforts to improve cancer drug efficacy
    Dheva Setiaputra
    Salomé Adam
   Discovery Corner
    Not your typical March Break: the life of an intern at the LTRI
  COVID-19
  Aside
   Slides relating to the recommendations of CANADA'S FUNDAMENTAL SCIENCE REVIEW